Drug Induced Liver Injury (DILI)
Drugs are an important cause of liver damage. More than nine hundred medications, toxins, and herbs have been reported to cause liver damage, and drugs represent twenty to forty percent of all cases of fulminant hepatic failure. Roughly seventy five percent of the idiosyncratic drug reactions result in liver transplantation or death. Drug-induced hepatic injury is the most common reason cited for withdrawal of an approved drug. Knowledge of the commonly implicated agents and a high index of suspicion are essential in diagnosis.
Related Conference of Drug Induced Liver Injury (DILI)
October 20-21, 2025
24th International Conference on Gastroenterology and Digestive Disorders
Osaka, Japan
January 19-20, 2026
26th International Conference on Gastroenterology and Hepatology
Vienna, Austria
April 20-21, 2026
20th World Congress on Gastroenterology -Therapeutics & Hepatology
Barcelona, Spain
May 21-22, 2026
17th International Conference on Liver Diseases & Hepatology
Aix-en-Provence, France
Drug Induced Liver Injury (DILI) Conference Speakers
Recommended Sessions
- Cirrhosis of Liver
- Drug Induced Liver Injury (DILI)
- Hepatitis
- Hepatitis B and Other Viral Hepatitis
- Hepatobiliary diseases
- Liver Cancer
- Liver Fibrosis
- Liver Growth and repair
- Liver Inflammation and Immunobiology
- Liver Transplantation and Liver Surgery (experimental & clinical)
- Neuro-Gastroenterology
- Other Liver Diseases
- Pancreatitis
- Pediatric Hepatology
- Viral Hepatitis C
Related Journals
Are you interested in
- Advances in Gastrointestinal Oncology - WORLD GASTROENTEROLOGY 2026 (Spain)
- Advances in Gastrointestinal Therapeutics - Gastroenterology – 2025 (France)
- Advances in GERD Treatment - WORLD GASTROENTEROLOGY 2026 (Spain)
- Advances in Liver Transplantation - Gastroenterology-2025 (UAE)
- Advances in Pancreatic Disease Management - Gastroenterology-2025 (UAE)
- Alcoholic Liver Disease: Emerging Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Artificial Intelligence in Gastroenterology - Gastroenterology-2025 (UAE)
- Bariatric Endoscopy & Obesity Management - Gastroenterology-2025 (UAE)
- Barrett’s Esophagus: Current Therapeutics - WORLD GASTROENTEROLOGY 2026 (Spain)
- Celiac Disease and Gluten-Related Disorders - Gastroenterology – 2025 (France)
- Celiac Disease: Latest Treatment Options - WORLD GASTROENTEROLOGY 2026 (Spain)
- Cirrhosis & Portal Hypertension Management - Gastroenterology-2025 (UAE)
- Colorectal Cancer: Prevention, Screening, and Treatment - Gastroenterology – 2025 (France)
- Diagnostic Biomarkers and Therapeutic Targets in Digestive Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Digestive System Cancers - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Early Detection of Gastrointestinal Cancers - Gastroenterology-2025 (UAE)
- Emerging Biomarkers in Gastroenterology - Gastroenterology-2025 (UAE)
- Emerging Therapies for Crohn's - WORLD GASTROENTEROLOGY 2026 (Spain)
- Emerging Therapies for Inflammatory Bowel Disease - Gastroenterology-2025 (UAE)
- Endoscopic Innovations and Techniques - Gastroenterology – 2025 (France)
- Endoscopy and Minimally Invasive Gastrointestinal Procedures - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Esophageal Disorders: Current Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- FMT & Microbiota-Based Therapies - Gastroenterology-2025 (UAE)
- Functional GI Disorders & Motility Diseases - Gastroenterology-2025 (UAE)
- Functional GI Disorders: IBS and Beyond - Gastroenterology – 2025 (France)
- Gastrointestinal Disorders and Treatment - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Infections and Antimicrobial Resistance - Gastroenterology – 2025 (France)
- Gastrointestinal Infections and Immunity - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Oncology and Tumor Biology - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Oncology: From Screening to Targeted Therapies - Gastroenterology – 2025 (France)
- Gastrointestinal Stromal Tumors: Novel Therapies - WORLD GASTROENTEROLOGY 2026 (Spain)
- GI Bleeding & Emergency Endoscopy - Gastroenterology-2025 (UAE)
- GI Oncology: Colorectal and Pancreatic Cancers - Gastroenterology – 2025 (France)
- Gut Microbiome in GI Diseases - Gastroenterology-2025 (UAE)
- Gut Microbiota and Gastrointestinal Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gut Microbiota and Metabolic Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Hepatic Encephalopathy: Modern Management Strategies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatitis C Therapeutics - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatocellular Carcinoma: Latest Approaches - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatology: Liver Disease and Transplantation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Immunotherapy in GI Cancers - Gastroenterology-2025 (UAE)
- Inflammatory Bowel Disease (IBD): Crohn’s and Ulcerative Colitis - Gastroenterology – 2025 (France)
- Inflammatory Bowel Disease (IBD): Insights and Advancements - Gastroenterology – 2025 (France)
- Inflammatory Bowel Disease and Intestinal Inflammation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Innovations in Endoscopy - Gastroenterology-2025 (UAE)
- Innovations in IBD Management - WORLD GASTROENTEROLOGY 2026 (Spain)
- Liver and Pancreatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Cirrhosis and Complications - Gastroenterology – 2025 (France)
- Liver Cirrhosis: New Therapies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Liver Diseases and Hepatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Diseases and Hepatology - Gastroenterology – 2025 (France)
- Microbiome and Gastrointestinal Health - WORLD GASTROENTEROLOGY 2026 (Spain)
- Microbiome and Gut Health - Gastroenterology – 2025 (France)
- NAFLD & NASH Management - Gastroenterology-2025 (UAE)
- NAFLD and NASH Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- New Approaches to Peptic Ulcer Disease - WORLD GASTROENTEROLOGY 2026 (Spain)
- Non-Alcoholic Fatty Liver Disease - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Non-Alcoholic Fatty Liver Disease (NAFLD) and NASH - Gastroenterology – 2025 (France)
- Nutrition & Liver Health - Gastroenterology-2025 (UAE)
- Nutrition and Aging: Geriatric Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pancreatitis: Modern Therapeutic Strategies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Pediatric and Adolescent Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pediatric Gastroenterology and Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pediatric Gastroenterology Breakthroughs - Gastroenterology-2025 (UAE)
- Pediatric Gastroenterology: Challenges and Innovations - Gastroenterology – 2025 (France)
- Peptic Ulcer and Acid-related Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Peptic Ulcer Disease and H. pylori Infection - Gastroenterology – 2025 (France)
- Plant-Based Nutrition and Sustainable Diets - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Post-COVID GI Complications - Gastroenterology-2025 (UAE)
- Precision Medicine in Hepatology - Gastroenterology-2025 (UAE)
- Role of Microbiota in Digestive Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Therapeutics for Biliary Diseases - WORLD GASTROENTEROLOGY 2026 (Spain)
- Ulcerative Colitis: Innovative Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Viral Hepatitis Treatment Innovations - Gastroenterology-2025 (UAE)
- Viral Hepatitis: New Treatment Paradigms - WORLD GASTROENTEROLOGY 2026 (Spain)